A
Almut Scherer
Researcher at University of Zurich
Publications - 59
Citations - 1204
Almut Scherer is an academic researcher from University of Zurich. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 14, co-authored 46 publications receiving 883 citations. Previous affiliations of Almut Scherer include Bethesda Hospital & University Hospital of Lausanne.
Papers
More filters
Journal ArticleDOI
TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort
Christoph Molnar,Almut Scherer,Xenofon Baraliakos,Manouk de Hooge,Raphael Micheroli,Pascale Exer,Rudolf O. Kissling,Giorgio Tamborrini,Lukas M Wildi,Michael John Nissen,Pascal Zufferey,Jürg Bernhard,Ulrich Weber,Robert Landewé,Désirée van der Heijde,Adrian Ciurea +15 more
TL;DR: TNFis are associated with a reduction of spinal radiographic progression in patients with AS, and this effect seems mediated through the inhibiting effect of TNFi on disease activity.
Journal ArticleDOI
Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort.
Adrian Ciurea,Almut Scherer,Pascale Exer,Jürg Bernhard,Jean Dudler,Brigitte Beyeler,Rudolf O. Kissling,Daniel J. Stekhoven,Kaspar Rufibach,Giorgio Tamborrini,Bettina Weiss,Rüdiger Müller,Michael John Nissen,Beat A. Michel,Désirée van der Heijde,Maxime Dougados,Annelies Boonen,Ulrich Weber +17 more
TL;DR: The indications for treatment with anti-TNF agents were comparable for patients with radiographic axial SpA and those with nonradiographic axIAL SpA.
Journal ArticleDOI
Chronic NSAID use and long-term decline of renal function in a prospective rheumatoid arthritis cohort study
TL;DR: NSAIDs had no negative impact on renal function estimates but in patients with advanced renal impairment, and were an independent predictor for accelerated renal function decline only in patientsWith advanced baseline renal impairment (eGFRCG <30 mL/min).
Journal ArticleDOI
Effectiveness of biologic DMARDs in monotherapy versus in combination with synthetic DMARDs in rheumatoid arthritis: data from the Swiss Clinical Quality Management Registry
TL;DR: BDMARD monotherapy is prescribed to more complex cases and is significantly less effective than bDMARD therapy in combination with sDMARDs, but to an extent that is clinically only marginally relevant.
Journal ArticleDOI
Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis.
Raphael Micheroli,Monika Hebeisen,Lukas M Wildi,Pascale Exer,Giorgio Tamborrini,Jürg Bernhard,Burkhard Möller,Pascal Zufferey,Michael John Nissen,Almut Scherer,Adrian Ciurea +10 more
TL;DR: Obesity is associated with significantly lower response rates to TNFi in patients with axSpA and significantly lower odds ratios (ORs) for achieving ASAS40 response were found in adjusted analyses in obese patients versus patients with normal BMI.